Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combined polynucleotide sequence as discrete assay endpoints

Combined polynucleotide sequence as discrete assay endpoints

US Patent 6316608 · Granted Nov 13, 2001

Estimated economic value: $16,710,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Multiphase nucleic acid amplification2025
Formulations of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)me2024
Formulations of 6-(2-hydroxy-methylpropoxy-4-(6-(6-((6-methoxypyridin-3-yl)methy2024
Formulations of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)me2024
Multiphase nucleic acid amplification2024
Liquid formulations of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyr2022
Synthesis of pools of probes by primer extension2022
Process for the preparation of (S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-2022
Capture probes immobilizable via L-nucleotide tail2021
Capture probes immobilizable via L-nucleotide tail2021
Methods for amplification of nucleic acids utilizing clamp oligonucleotides2021
Formulations of 6-(2-hydroxy-2-methylpropxy)-4-(6-(6-((6-methoxypyridin-3-yl)met2020